格隆汇11月10日丨达安基因(002030.SZ)在投资者互动平台表示，公司开发有针对甲型、乙型流感病毒 的检测试剂产品，可以适配甲、乙流常规分型的病毒检测需求。公司会持续跟踪流感病毒变异情况，以 获取最新检测需求动态。 ...

Group 1 - The company has developed testing reagents for both influenza A and B viruses, catering to the routine classification needs for these viruses [1] - The company will continuously monitor the mutation of influenza viruses to stay updated on the latest testing demand dynamics [1]